FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063058393> ?p ?o ?g. }

• W2063058393 endingPage "2520" @default.
• W2063058393 startingPage "2511" @default.
• W2063058393 abstract "BACKGROUND Indole-3-carbinol (I3C), a naturally occurring component of Brassica vegetables, such as cabbage, broccoli, and Brussels sprouts, is a promising anticancer agent for certain reproductive tumor cells. The objective of the current study was to characterize the cell cycle effects of I3C in human prostate carcinoma cells. METHODS The incorporation of [3H]thymidine and flow cytometry of propidium iodide–stained nuclei were used to monitor I3C-regulated changes in prostate carcinoma cell proliferation and cell cycle progression. Western blotting was used to document expression changes in cell cycle components and prostate-specific antigen (PSA) levels. The enzymatic activities of cyclin-dependent kinases (CDK) were tested by in vitro protein kinase assays using the retinoblastoma protein as a substrate. RESULTS I3C suppressed the growth of LNCaP prostate carcinoma cells in a dose-dependent manner by inducing a G1 block in cell cycle progression. I3C selectively inhibited the expression of CDK6 protein and transcripts and strongly stimulated the production of the p16 CDK inhibitor. In vitro protein kinase assays revealed the striking inhibition by I3C of immunoprecipitated CDK2 enzymatic activity and the relatively minor down-regulation of CDK4 enzymatic activity. In LNCaP prostate carcinoma cells, I3C treatment inhibited production of PSA, whereas combinations of I3C and the androgen antagonist flutamide more effectively inhibited DNA synthesis and PSA levels compared with either agent alone. CONCLUSIONS The results of the current study demonstrated that I3C has a potent antiproliferative effect in LNCaP and other human prostate carcinoma cells. These findings implicate this dietary indole as a potential chemotherapeutic agent for controlling the growth of human prostate carcinoma cells. Cancer 2003. © 2003 American Cancer Society." @default.
• W2063058393 created "2016-06-24" @default.
• W2063058393 creator A5008109270 @default.
• W2063058393 creator A5023224521 @default.
• W2063058393 creator A5061332692 @default.
• W2063058393 creator A5078794085 @default.
• W2063058393 creator A5081289468 @default.
• W2063058393 date "2003-11-17" @default.
• W2063058393 modified "2023-09-26" @default.
• W2063058393 title "Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells" @default.
• W2063058393 cites W1495102760 @default.
• W2063058393 cites W1606051673 @default.
• W2063058393 cites W1963764466 @default.
• W2063058393 cites W1970841622 @default.
• W2063058393 cites W1979805598 @default.
• W2063058393 cites W1985755415 @default.
• W2063058393 cites W1991395966 @default.
• W2063058393 cites W1996122427 @default.
• W2063058393 cites W1998248939 @default.
• W2063058393 cites W2000846615 @default.
• W2063058393 cites W2021353749 @default.
• W2063058393 cites W2029080338 @default.
• W2063058393 cites W2032611510 @default.
• W2063058393 cites W2054861419 @default.
• W2063058393 cites W2063344487 @default.
• W2063058393 cites W2069683989 @default.
• W2063058393 cites W2072088194 @default.
• W2063058393 cites W2076429988 @default.
• W2063058393 cites W2077613098 @default.
• W2063058393 cites W2078318155 @default.
• W2063058393 cites W2082989491 @default.
• W2063058393 cites W2089343966 @default.
• W2063058393 cites W2117965089 @default.
• W2063058393 cites W2137330819 @default.
• W2063058393 cites W2144023014 @default.
• W2063058393 cites W2145567281 @default.
• W2063058393 cites W2148180201 @default.
• W2063058393 cites W2156916332 @default.
• W2063058393 cites W2235954515 @default.
• W2063058393 cites W4245064765 @default.
• W2063058393 cites W4252138632 @default.
• W2063058393 cites W4253061118 @default.
• W2063058393 cites W85465741 @default.
• W2063058393 doi "https://doi.org/10.1002/cncr.11844" @default.
• W2063058393 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14635088" @default.
• W2063058393 hasPublicationYear "2003" @default.
• W2063058393 type Work @default.
• W2063058393 sameAs 2063058393 @default.
• W2063058393 citedByCount "67" @default.
• W2063058393 countsByYear W20630583932012 @default.
• W2063058393 countsByYear W20630583932013 @default.
• W2063058393 countsByYear W20630583932014 @default.
• W2063058393 countsByYear W20630583932015 @default.
• W2063058393 countsByYear W20630583932016 @default.
• W2063058393 countsByYear W20630583932017 @default.
• W2063058393 countsByYear W20630583932018 @default.
• W2063058393 countsByYear W20630583932019 @default.
• W2063058393 countsByYear W20630583932020 @default.
• W2063058393 countsByYear W20630583932021 @default.
• W2063058393 crossrefType "journal-article" @default.
• W2063058393 hasAuthorship W2063058393A5008109270 @default.
• W2063058393 hasAuthorship W2063058393A5023224521 @default.
• W2063058393 hasAuthorship W2063058393A5061332692 @default.
• W2063058393 hasAuthorship W2063058393A5078794085 @default.
• W2063058393 hasAuthorship W2063058393A5081289468 @default.
• W2063058393 hasBestOaLocation W20630583931 @default.
• W2063058393 hasConcept C121608353 @default.
• W2063058393 hasConcept C124320809 @default.
• W2063058393 hasConcept C126322002 @default.
• W2063058393 hasConcept C134018914 @default.
• W2063058393 hasConcept C190283241 @default.
• W2063058393 hasConcept C2775934118 @default.
• W2063058393 hasConcept C2776235491 @default.
• W2063058393 hasConcept C2779723316 @default.
• W2063058393 hasConcept C29537977 @default.
• W2063058393 hasConcept C31573885 @default.
• W2063058393 hasConcept C502942594 @default.
• W2063058393 hasConcept C55493867 @default.
• W2063058393 hasConcept C62112901 @default.
• W2063058393 hasConcept C71924100 @default.
• W2063058393 hasConcept C86803240 @default.
• W2063058393 hasConceptScore W2063058393C121608353 @default.
• W2063058393 hasConceptScore W2063058393C124320809 @default.
• W2063058393 hasConceptScore W2063058393C126322002 @default.
• W2063058393 hasConceptScore W2063058393C134018914 @default.
• W2063058393 hasConceptScore W2063058393C190283241 @default.
• W2063058393 hasConceptScore W2063058393C2775934118 @default.
• W2063058393 hasConceptScore W2063058393C2776235491 @default.
• W2063058393 hasConceptScore W2063058393C2779723316 @default.
• W2063058393 hasConceptScore W2063058393C29537977 @default.
• W2063058393 hasConceptScore W2063058393C31573885 @default.
• W2063058393 hasConceptScore W2063058393C502942594 @default.
• W2063058393 hasConceptScore W2063058393C55493867 @default.
• W2063058393 hasConceptScore W2063058393C62112901 @default.
• W2063058393 hasConceptScore W2063058393C71924100 @default.
• W2063058393 hasConceptScore W2063058393C86803240 @default.
• W2063058393 hasIssue "11" @default.
• W2063058393 hasLocation W20630583931 @default.

• next